← Back to Clinical Trials
Recruiting NCT05237817

Association Between Stroke and Adrenal Incidentalomas

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Stroke
Sponsor Xuanwu Hospital, Beijing
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2021-04-01
Completion 2022-04-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Adrenal incidentalomas (AIs) are commonly encountered in transsection imaging which purpose not for suspected adrenal disease. However, part of AIs in patients is associated with Stroke. Stroke is a diseases which could cause of disability and death worldwide. In clinical practice, detailed information about the association between stroke and AIs is not available. In this study, the investigators aimed to investigate the risk for disability and death in the large group of stroke patients with AIs.

Eligibility Criteria

Inclusion Criteria: * stroke disease , such as Cerebral infarction、Intracerebral hemorrhage and Subarachnoid hemorrhage. Exclusion Criteria: * presence of metastatic cancer; * AIs smaller than 1 cm; * nonadenoma lesions, such as myelolipomas,hemorrhages, and cysts; * oral glucocorticoid treatment with more than single doses in the past 3 months; * use of inhaled steroids or medication affecting dexamethasone metabolism; * systemic estrogen treatment.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}